264 related articles for article (PubMed ID: 37150538)
1. A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy.
Kianfar N; Dasdar S; Daneshpazhooh M; Aryanian Z; Goodarzi A
Exp Dermatol; 2023 Jul; 32(7):934-944. PubMed ID: 37150538
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of autoimmune bullous diseases in Middle Franconia.
Sollfrank L; Schönfelder V; Sticherling M
Front Immunol; 2023; 14():1256617. PubMed ID: 37881435
[TBL] [Abstract][Full Text] [Related]
3. Bullous autoimmune dermatoses.
Hofmann SC; Juratli HA; Eming R
J Dtsch Dermatol Ges; 2018 Nov; 16(11):1339-1358. PubMed ID: 30395395
[TBL] [Abstract][Full Text] [Related]
4. Blistering diseases in the mature patient.
Lakoš Jukić I; Jerković Gulin S; Marinović B
Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
[TBL] [Abstract][Full Text] [Related]
5. New immunomodulating drugs in autoimmune blistering diseases.
Korman NJ
Dermatol Clin; 2001 Oct; 19(4):637-48, viii. PubMed ID: 11705351
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Immunoglobulin for Autoimmune Bullous Diseases: A Case Series from a Central European Referral Center.
Spałek MM; Bowszyc-Dmochowska M; Dmochowski M
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512078
[No Abstract] [Full Text] [Related]
7. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.
Czernik A; Toosi S; Bystryn JC; Grando SA
Autoimmunity; 2012 Feb; 45(1):111-8. PubMed ID: 21923613
[TBL] [Abstract][Full Text] [Related]
8. Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.
Bohelay G; Alexandre M; Le Roux-Villet C; Sitbon I; Doan S; Soued I; Shourick J; Rousset L; Mellottee B; Heller M; Lièvre N; Zumelzu C; Morin F; Grootenboer-Mignot S; Gabison E; Caux F; Prost-Squarcioni C; Musette P
Front Immunol; 2022; 13():915205. PubMed ID: 35844526
[TBL] [Abstract][Full Text] [Related]
9. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.
Santi CG; Gripp AC; Roselino AM; Mello DS; Gordilho JO; Marsillac PF; Porro AM
An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):33-47. PubMed ID: 31166405
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.
Lamberts A; Euverman HI; Terra JB; Jonkman MF; Horváth B
Front Immunol; 2018; 9():248. PubMed ID: 29520266
[TBL] [Abstract][Full Text] [Related]
11. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders.
Jolles S
Clin Exp Dermatol; 2001 Mar; 26(2):127-31. PubMed ID: 11298100
[TBL] [Abstract][Full Text] [Related]
12. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
[TBL] [Abstract][Full Text] [Related]
13. High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.
Jolles S
Clin Exp Immunol; 2002 Sep; 129(3):385-9. PubMed ID: 12197877
[No Abstract] [Full Text] [Related]
14. Nutrition and bullous diseases.
Stoj V; Lu J
Clin Dermatol; 2022; 40(2):156-165. PubMed ID: 34808244
[TBL] [Abstract][Full Text] [Related]
15. Treatment Update of Autoimmune Blistering Diseases.
Kridin K; Ahn C; Huang WC; Ansari A; Sami N
Dermatol Clin; 2019 Apr; 37(2):215-228. PubMed ID: 30850044
[TBL] [Abstract][Full Text] [Related]
16. [Bullous autoimmune dermatoses of the mucous membranes].
Didona D; Hinterseher J; Eming R
Dermatologie (Heidelb); 2022 Sep; 73(9):692-700. PubMed ID: 36006424
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in refractory autoimmune bullous diseases.
Schmidt E; Hunzelmann N; Zillikens D; Bröcker EB; Goebeler M
Clin Exp Dermatol; 2006 Jul; 31(4):503-8. PubMed ID: 16716150
[TBL] [Abstract][Full Text] [Related]
18. The autoimmune bullous diseases.
Wakelin SH; Black MM
J R Coll Physicians Lond; 1997; 31(4):364-8. PubMed ID: 9263961
[No Abstract] [Full Text] [Related]
19. Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management.
Kim M; Borradori L; Murrell DF
Drugs Aging; 2016 Oct; 33(10):711-723. PubMed ID: 27738963
[TBL] [Abstract][Full Text] [Related]
20. The pathogeneses of pemphigus and pemphigoid diseases.
Ujiie H; Yamagami J; Takahashi H; Izumi K; Iwata H; Wang G; Sawamura D; Amagai M; Zillikens D
J Dermatol Sci; 2021 Dec; 104(3):154-163. PubMed ID: 34916040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
